Literature DB >> 8397048

High D-glucose concentrations increase GABA release but inhibit release of norepinephrine and 5-hydroxytryptamine in rat cerebral cortex.

K Fink1, M Göthert.   

Abstract

The effect of high D-glucose concentrations on the K+ (15-25 mM)-evoked release of [3H]GABA, [3H]norepinephrine ([3H]NE), [3H]5-hydroxy- tryptamine ([3H]5-HT) and [3H]acetylcholine ([3H]ACh) was investigated in rat cerebral cortical slices and synaptosomes superfused with Krebs' solution which normally contains 11.1 mM glucose. In slices, the release of [3H]GABA was enhanced by increasing D-glucose by 32-320 mM, the release of [3H]NE and [3H]5-HT was inhibited when D-glucose was increased by 60-320 mM but the release of [3H]ACh was not affected. The increase of [3H]GABA release and the inhibition of [3H]NE release were mimicked by D-fructose and NaCl at similar osmolarities, whereas dimethylsulfoxide (DMSO; a freely membrane-permeable drug) at equimolar concentrations failed to affect the release of [3H]GABA and [3H]NE. The GABAB receptor antagonist p-(3-aminopropyl)-p-diethoxymethyl- phosphinic acid (CGP 35348) abolished the inhibitory effect of an increase in D-glucose by 60 and 100 mM on [3H]NE release but only tended to diminish the inhibition caused by an increase by 320 mM. In synaptosomes, the K(+)-evoked release of 3H-GABA was enhanced by increasing D-glucose by 60-320 mM. The K(+)-evoked release of [3H]NE was only inhibited when D-glucose was increased by 320 mM, whereas it was not affected by an increase by 100 mM. In conclusion, high D-glucose differentially influences neurotransmitter release in the brain cortex. Hyperosmolarity in the extracellular fluid together with an osmotic gradient extra- versus intracellular probably plays a role in the mechanism(s) underlying the changes observed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8397048     DOI: 10.1016/0006-8993(93)91269-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Hippocampal infusions of pyruvate reverse the memory-impairing effects of septal muscimol infusions.

Authors:  Desiree L Krebs; Marise B Parent
Journal:  Eur J Pharmacol       Date:  2005-09-27       Impact factor: 4.432

2.  Both ethanol and ifenprodil inhibit NMDA-evoked release of various neurotransmitters at different, yet proportional potency: potential relation to NMDA receptor subunit composition.

Authors:  K Fink; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

3.  GTSF-2: a new, versatile cell culture medium for diverse normal and transformed mammalian cells.

Authors:  P I Lelkes; E Ramos; V V Nikolaychik; D M Wankowski; B R Unsworth; T J Goodwin
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-05       Impact factor: 2.416

4.  Septal co-infusions of glucose with a GABAB agonist impair memory.

Authors:  Erika J Erickson; Kelly D Watts; Marise B Parent
Journal:  Neurobiol Learn Mem       Date:  2005-10-11       Impact factor: 2.877

5.  Hippocampal infusions of glucose reverse memory deficits produced by co-infusions of a GABA receptor agonist.

Authors:  Desiree L Krebs-Kraft; Marise B Parent
Journal:  Neurobiol Learn Mem       Date:  2007-08-28       Impact factor: 2.877

6.  Reactive oxygen species, apoptosis and altered NGF-induced signaling in PC12 pheochromocytoma cells cultured in elevated glucose: an in vitro cellular model for diabetic neuropathy.

Authors:  E Lelkes; B R Unsworth; P I Lelkes
Journal:  Neurotox Res       Date:  2001-04       Impact factor: 3.911

7.  Zero net flux estimates of septal extracellular glucose levels and the effects of glucose on septal extracellular GABA levels.

Authors:  Desiree L Krebs-Kraft; Gail Rauw; Glen B Baker; Marise B Parent
Journal:  Eur J Pharmacol       Date:  2009-04-01       Impact factor: 4.432

Review 8.  Serotonin and beyond-a tribute to Manfred Göthert (1939-2019).

Authors:  H Bönisch; K B Fink; B Malinowska; G J Molderings; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-05-15       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.